Get the Stockscreener App
19.06
1.38%
0.26
Pre-market:
18.90
-0.16
-0.84%
Caredx Inc stock is traded at $19.06, with a volume of 389.25K.
It is up +1.38% in the last 24 hours and up +0.69% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$18.80
Open:
$18.81
24h Volume:
389.25K
Relative Volume:
0.54
Market Cap:
$980.31M
Revenue:
$358.00M
Net Income/Loss:
$70.45M
P/E Ratio:
15.98
EPS:
1.1924
Net Cash Flow:
$36.42M
1W Performance:
+3.25%
1M Performance:
+0.69%
6M Performance:
+45.50%
1Y Performance:
-6.11%
1-Day Range:
$18.63
$19.33
1-Week Range:
$17.62
$19.33
52-Week Range:
$10.96
$21.48
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
19.06 | 966.93M | 358.00M | 70.45M | 36.42M | 1.1924 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
ARK Investment Management LLC Buys 70,468 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Amova Asset Management Americas Inc. - MarketBeat
Caredex Stock Quote, Share Price, News and Analysis - Longbridge
CDNA,SPOK Options - Finviz
(CDNA) Risk Channels and Responsive Allocation - Stock Traders Daily
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI) - The Globe and Mail
BTIG Raises CareDx (CDNA) Price Target to $26.00, Maintains Buy Rating | CDNA Stock News - GuruFocus
CareDx (CDNA) Returns To Q4 Loss As Revenue Growth Tests Bullish Narratives - simplywall.st
BTIG raises CareDx stock price target to $26 on strong Q4 results - Investing.com Canada
CareDx, Inc Q4 2025 Earnings Call Summary - Yahoo Finance
CareDx (CDNA) grows 2025 revenue 14% and guides higher for 2026 - Stock Titan
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating - TipRanks
CareDx Names COO to Additional CFO Post - Contract Pharma
CareDx (CDNA) Receives Rating Update: Wells Fargo Raises Price T - GuruFocus
CareDx (NASDAQ:CDNA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
CareDx (NASDAQ:CDNA) Shares Gap Down After Earnings Miss - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q4 2025 Earnings Call Transcript - Insider Monkey
CareDx: Fourth Quarter Financial Overview - Bitget
CareDx Names New CFO Amid Strong Q4 2025 Results - The Globe and Mail
CareDx Inc (CDNA) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
CareDx Q4 Earnings Call Highlights - MarketBeat
CareDx, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CDNA) 2026-02-24 - Seeking Alpha
CareDx names COO Keith Kennedy as chief financial officer - Investing.com India
CareDx names COO Keith Kennedy as chief financial officer By Investing.com - Investing.com Australia
CareDx (NASDAQ:CDNA) Announces Earnings Results - MarketBeat
CareDx (CDNA) Reports Q4 Earnings: What Key Metrics Have to Say - Nasdaq
CareDx (CDNA) Announces Key Leadership Change as COO Takes on CF - GuruFocus
CareDx (CDNA) Q4 Earnings Miss Estimates - Yahoo Finance
CareDx (CDNA) Q4 2025 Earnings Call Transcript - Intellectia AI
CareDx Inc (NASDAQ:CDNA) Reports Strong Revenue Beat but Profitability Concerns Weigh on Shares - ChartMill
Caredx Inc says Keith Kennedy appointed as CFO and COOSEC filing - marketscreener.com
Caredx Inc Says Keith Kennedy Appointed As CFO And COOSEC Filing - TradingView
Caredx announces appointment of Keith Kennedy as chief operating officer and chief financial officer - marketscreener.com
CareDx (CDNA) Exceeds Q4 Revenue Expectations, Eyes Future Growt - GuruFocus
CDNA Forecasts FY26 Adjusted EBITDA Between $30M-$45M - GuruFocus
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer - Business Wire
CareDx Q4 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
Earnings Flash (CDNA) CareDx, Inc. Reports Q4 Revenue $108.4M, vs. FactSet Est of $103.3M - marketscreener.com
Earnings Flash (CDNA) CareDx, Inc. Posts Q4 Adjusted EPS $0.12 per Share, vs. FactSet Est of $0.24 - marketscreener.com
CareDx: Q4 Earnings Insights - Benzinga
CareDx Announces Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
Comparing CareDx (NASDAQ:CDNA) and Elevance Health (NYSE:ELV) - Defense World
Justices Want Natera's Take On CareDx's False Ad Petition - Law360
Uncovering Potential: CareDx's Earnings Preview - Benzinga
Jupiter Asset Management Ltd. Sells 128,669 Shares of CareDx, Inc. $CDNA - MarketBeat
AlloHeme Clinical Validation Could Be A Game Changer For CareDx’s (CDNA) Transplant Platform Expansion - Sahm
Growth Review: Should you avoid CareDx Inc stock right now2025 Trading Recap & Free Community Supported Trade Ideas - baoquankhu1.vn
Risk Hedge: Can Navitas Semiconductor Corporation disrupt its industryQuarterly Portfolio Review & Expert Curated Trade Ideas - baoquankhu1.vn
CareDx (CDNA) to Announce Earnings on Tuesday - Defense World
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):